Remimazolam vs midazolam for deep sedation in critically ill patients on a ventilator
Treatments studied
This study compares two sedative medicines, remimazolam and midazolam, for people who are on a ventilator and need deep sedation despite unstable blood pressure. The goal is to see which drug is safer and more effective for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are on a breathing machine (ventilator) and will need sedation for at least 24 hours.
- Your blood pressure is low and you need medicines (vasopressors) to keep it up, even after receiving fluids.
- You have signs of poor blood flow, such as high blood lactic acid, low urine output, mottled skin, or confusion.
- You are not pregnant, do not have severe liver failure, are not on ECMO, do not have uncontrolled seizures, and are not allergic to sedatives.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two sedation medicines—remimazolam vs midazolam—for very sick ICU patients who are on a breathing machine. It looks at whether one sedative works better or is safer for keeping patients comfortable while they’re critically ill.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study tests a combination of two sedative drugs (remazolam besylate and remifentanil) for calming patients with sepsis who are on a ventilator in the ICU. The goal is to see if this approach improves recovery compared to standard care.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study compares two different sedative medicines, remimazolam and midazolam, to see which works better for people having a routine upper GI endoscopy (a camera test to look at your stomach and esophagus). If you are scheduled for this procedure and need sedation, you may be able to join.
Hear when a new Critical Illness; Mechanical Ventilation; Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.